NCL Technology Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 26
  • Portfolio
  • 18
  • Exits
  • 4
Exits

NCL Technology Ventures General Information

Description

Founded in 2010, NCL Technology Ventures is a venture capital firm based in London, United Kingdom. The firm is focused on investing in seed and early-stage companies. The firm seeks to make investments in the medical technologies, digital health, and therapeutics sectors.

Contact Information

Website
www.ncltv.co.uk
Formerly Known As
Narec Capital
Year Founded
2010
Investor Status
Actively Seeking New Investments
Trade Association
British Venture Capital Association (BRVCA)
Primary Investor Type
Venture Capital
Primary Office
  • 3 Wimpole Street
  • London W1G 9SQ
  • England, United Kingdom
+44 020 0000 0000

NCL Technology Ventures Investments (26)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Centauri Therapeutics 16-Feb-2022 Later Stage VC 000.00 Drug Discovery Generating Revenue 00000000 000000
000000000 000000 ( 27-Jul-2020 00000 00000 00.000 Other Healthcare Services Generating Revenue 00000000 000000
0000000000 05-Jun-2020 00000 00000 00.000 Discovery Tools (Healthcare) Generating Revenue 00000000 000000
0000 000000 07-Aug-2019 00000 00000 00000 Therapeutic Devices Generating Revenue
000000000 000000 01-Jul-2019 00000 00000 00000 Clinics/Outpatient Services Generating Revenue
000000 05-Apr-2019 00000 00000 00000 Monitoring Equipment Generating Revenue
00000 01-Apr-2019 00000 00000 00.000 Other Devices and Supplies Generating Revenue 000000 00000
0000000 01-Feb-2019 00000 00000 000 Biotechnology Generating Revenue 00000000 000000
TC Biopharm 17-Dec-2018 Later Stage VC 00000 Drug Discovery Generating Revenue/Not Profitable
Centauri Therapeutics 01-Dec-2018 Early Stage VC 00.000 Drug Discovery Generating Revenue 00000000 000000
You’re viewing 10 of 26 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NCL Technology Ventures Exits (4)

Company Name Exit Date Exit Type Exit Size
TC Biopharm 11-Feb-2022 IPO
0000000000 0000000 31-Dec-2019 000000000000000000
Flute Office 16-May-2018 Bankruptcy: Liquidation
Sienna Biopharmaceuticals 27-Jul-2017 IPO 0000
To view NCL Technology Ventures’s complete exits history, request access »

NCL Technology Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

NCL Technology Ventures Team (22)

Name Title Deals Funds Boards Office
Jeremy Biggs Chief Executive Officer, Board Member & Founding Director 0 0 0 London, United Kingdom
Patrick O'Neill President, US Operations New Haven, CT
Nicholas Ibery General Partner & Global Head of Healthcare Investments London, United Kingdom
Jonathan Synett Chief Investment Officer & Board Member 0 0 0 London, United Kingdom
Graham Hutchins Operations Director London, United Kingdom
You’re viewing 5 of 22 team members. Get the full list »

NCL Technology Ventures Co-Investors (20)

Name With Exits Lead Partner Series Industry
Evotec 1 0 Series chart Industry bar
HealthTech Capital 0 Series chart Industry bar
Novo Holdings 0 0 Series chart Industry bar
Plug and Play Tech Center 0 Series chart Industry bar
Wren Capital 0 0 Series chart Industry bar
You’re viewing 5 of 20 co-investors. Get the full list »